Cargando…

Elite controllers long-term non progressors present improved survival and slower disease progression

Different phenotypes exhibiting no evidences of disease progression have been described in ART-naïve HIV-1 positive individuals. Long-term non progressors (LTNP) and elite controllers (EC) are low frequent examples of immunological and virological control in HIV-1 positive subjects, respectively. Th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Capa, Laura, Ayala-Suárez, Rubén, De La Torre Tarazona, Humberto Erick, González-García, Juan, del Romero, Jorge, Alcamí, José, Díez-Fuertes, Francisco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9522853/ https://www.ncbi.nlm.nih.gov/pubmed/36175445 http://dx.doi.org/10.1038/s41598-022-19970-3

Ejemplares similares

Insight in miRNome of Long-Term Non-Progressors and Elite Controllers Exposes Potential RNAi Role in Restraining HIV-1 Infection
por: Ayala-Suárez, Rubén, et al.
Publicado: (2020)

Transcriptome Sequencing of Peripheral Blood Mononuclear Cells from Elite Controller-Long Term Non Progressors
por: Díez-Fuertes, Francisco, et al.
Publicado: (2019)

Omic Technologies in HIV: Searching Transcriptional Signatures Involved in Long-Term Non-Progressor and HIV Controller Phenotypes
por: De La Torre-Tarazona, Erick, et al.
Publicado: (2022)

Novel association of five HLA alleles with HIV-1 progression in Spanish long-term non progressor patients
por: Ramírez de Arellano, Eva, et al.
Publicado: (2019)

Comparable antiviral capacity but favorable in vitro survival of CD8s from elite controllers compared to untreated progressors
por: Shasha, D, et al.
Publicado: (2012)

Distinct Tryptophan Catabolism and Th17/Treg Balance in HIV Progressors and Elite Controllers
por: Jenabian, Mohammad-Ali, et al.
Publicado: (2013)

Octogenarians with chronic kidney disease in the nephrology clinic: Progressors vs. non-progressors
por: Frías, Aida, et al.
Publicado: (2023)

Correction: Distinct Tryptophan Catabolism and Th17/Treg Balance in HIV Progressors and Elite Controllers
por: Jenabian, Mohammad-Ali, et al.
Publicado: (2014)

Distinct Plasma Concentrations of Acyl-CoA-Binding Protein (ACBP) in HIV Progressors and Elite Controllers
por: Isnard, Stéphane, et al.
Publicado: (2022)

The “slower” the better
por: Pala, L., et al.
Publicado: (2014)

Characterization of broadly neutralizing antibody responses to HIV-1 in a cohort of long term non-progressors
por: González, Nuria, et al.
Publicado: (2018)

Differential MicroRNA Expression Profile between Stimulated PBMCs from HIV-1 Infected Elite Controllers and Viremic Progressors
por: Egaña-Gorroño, Lander, et al.
Publicado: (2014)

Fatter, older and slower (and with a trigger)
por: Antonella Del Rosso
Publicado: (2013)

Are Long-Term Non-Progressors Very Slow Progressors? Insights from the Chelsea and Westminster HIV Cohort, 1988–2010
por: Mandalia, Sundhiya, et al.
Publicado: (2012)

Viral Reservoirs in Lymph Nodes of FIV-Infected Progressor and Long-Term Non-Progressor Cats during the Asymptomatic Phase
por: Eckstrand, C. D., et al.
Publicado: (2016)

Array Comparative Genomic Hybridization in Ulcerative Colitis Neoplasia: Single Non-Dysplastic Biopsies Distinguish Progressors from Non-Progressors
por: Bronner, Mary P., et al.
Publicado: (2010)

Factors associated with conversion of long-term non-progressors to progressors: A prospective study of HIV perinatally infected paediatric survivors
por: Radhakrishna, Muttineni, et al.
Publicado: (2013)

S03-04 OA. Transitional and central memory CD4 T cells are highly infected in long term non progressors and elite controllers
por: Descours, B, et al.
Publicado: (2009)

An integrative genomic analysis of transcriptional profiles identifies characteristic genes and patterns in HIV-infected long-term non-progressors and elite controllers
por: Ding, Jiwei, et al.
Publicado: (2019)

Vitamin D supplementation is associated with slower epigenetic aging
por: Vetter, Valentin Max, et al.
Publicado: (2022)

TP53/p53 alterations and Aurora A expression in progressor and non-progressor colectomies from patients with longstanding ulcerative colitis
por: FRIIS-OTTESSEN, MARIANN, et al.
Publicado: (2015)

HIV-specific T-cell Responses and Generalized Activation in HIV-1 Infected Long-term Non-progressors and Progressors from South India
por: Swathirajan, Chinnambedu Ravichandran, et al.
Publicado: (2018)

Evaluation of Rapid Progressors in HIV Infection as an Extreme Phenotype
por: Olson, Ashley D., et al.
Publicado: (2014)

Long term non-progressor (LTNP) HIV infection
por: Kumar, Praveen
Publicado: (2013)

Percentage of progressors in imaging: can we ignore regressors?
por: Sepriano, Alexandre, et al.
Publicado: (2019)

The Slower Method the Truer One
Publicado: (1896)

Identification of progressors in osteoarthritis by combining biochemical and MRI-based markers
por: Dam, Erik B, et al.
Publicado: (2009)

Serological identification of fast progressors of structural damage with rheumatoid arthritis
por: Siebuhr, Anne Sofie, et al.
Publicado: (2013)

Comparison of the Biological Basis for Non-HIV Transmission to HIV-Exposed Seronegative Individuals, Disease Non-Progression in HIV Long-Term Non-Progressors and Elite Controllers
por: Hokello, Joseph, et al.
Publicado: (2023)

Elite long jumpers with below the knee prostheses approach the board slower, but take-off more effectively than non-amputee athletes
por: Willwacher, Steffen, et al.
Publicado: (2017)

Slower saccadic reading in Parkinson’s disease
por: Jehangir, Naz, et al.
Publicado: (2018)

Increased Prevalence of Unstable HLA-C Variants in HIV-1 Rapid-Progressor Patients
por: Stefani, Chiara, et al.
Publicado: (2022)

The number of CCR5 expressing CD4+ T lymphocytes is lower in HIV-infected long-term non-progressors with viral control compared to normal progressors: a cross-sectional study
por: Meijerink, Hinta, et al.
Publicado: (2014)

Immune response and reactogenicity after immunization with two-doses of an experimental COVID-19 vaccine (CVnCOV) followed by a third-fourth shot with a standard mRNA vaccine (BNT162b2): RescueVacs multicenter cohort study
por: Ascaso-del-Rio, Ana, et al.
Publicado: (2022)

Cool down: getting further by going slower
por: Prentice, Steven
Publicado: (2007)

Human Faces Are Slower than Chimpanzee Faces
por: Burrows, Anne M., et al.
Publicado: (2014)

Half-marathoners are younger and slower than marathoners
por: Knechtle, Beat, et al.
Publicado: (2016)

Kv1 channel inactivation: Slow and slower
por: Short, Ben
Publicado: (2022)

Baseline clinical characteristics of predicted structural and pain progressors in the IMI-APPROACH knee OA cohort
por: van Helvoort, Eefje Martine, et al.
Publicado: (2021)

Preferential targeting of co-evolving Gag residues in long-term non progressors
por: Sunshine, J, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_su6nlq785pfq2barn4lmna6n6m